BPG is committed to discovery and dissemination of knowledge
Featured Articles
4/21/2026 9:02:01 AM | Browse: 55 | Download: 102
 |
Received |
|
2025-12-15 03:44 |
|
Peer-Review Started |
|
2025-12-15 03:44 |
|
First Decision by Editorial Office Director |
|
2025-12-25 08:21 |
|
Return for Revision |
|
2025-12-25 08:21 |
|
Revised |
|
2026-01-05 06:30 |
|
Publication Fee Transferred |
|
2026-01-09 10:22 |
|
Second Decision by Editor |
|
2026-02-11 02:36 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-11 07:01 |
|
Articles in Press |
|
2026-02-11 07:01 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-04-02 08:04 |
|
Publish the Manuscript Online |
|
2026-04-21 09:00 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Breast cancer and metabolic comorbidities: From epidemiology and molecular mechanisms to precision interventions
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shen-Hao Zhang, Yang Yang and Yuan Zhang |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yuan Zhang, PhD, Medical College, Yanbian University, No. 977 Gongyuan Road, Yanji 133002, Jilin Province, China. 0000008641@ybu.edu.cn |
| Key Words |
Breast cancer; Metabolic comorbidities; Obesity; Type 2 diabetes mellitus; Precision interventions |
| Core Tip |
Reframes metabolic comorbidities as active, modifiable drivers of breast cancer. Integrates epidemiology, tumour microenvironment, signalling and gut microbiota. Maps obesity, type 2 diabetes mellitus and metabolic syndrome pathways to pharmacologic and lifestyle interventions. Highlights glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter 2 inhibitors and bariatric surgery as precision tools. Proposes a metabolic oncology model with artificial intelligence-enabled multimodal risk prediction. |
| Publish Date |
2026-04-21 09:00 |
| Citation |
Zhang SH, Yang Y, Zhang Y. Breast cancer and metabolic comorbidities: From epidemiology and molecular mechanisms to precision interventions. World J Clin Oncol 2026; 17(4): 117705 |
| URL |
https://www.wjgnet.com/2218-4333/full/v17/i4/117705.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v17.i4.117705 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
